ARTICLE | Company News
Illumina shells out $100M for Edico Genome acquisition
May 18, 2018 2:31 AM UTC
Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million.
SVP of Product Development Susan Tousi told BioCentury that Illumina will use Edico's DRAGEN Bio-IT Platform to accelerate secondary analysis of next generation sequencing data. DRAGEN can analyze a whole genome in about 25 minutes, compared with about 30 hours when using industry standard BWA-GATK-HC software (see BioCentury, July 21, 2014 & BioCentury Innovations, Feb. 14, 2018)...